Detection of autoantibodies and increased concentrations of interleukins in plasma from patients with Tourette's syndrome

J Mol Neurosci. 2012 Sep;48(1):219-24. doi: 10.1007/s12031-012-9811-8. Epub 2012 May 26.

Abstract

The aim of this study was to assess levels of autoantibodies and cytokines in patients with Tourette's syndrome (TS, n = 40) and healthy control individuals (n = 40). Plasma interleukin (IL)-1β, IL-6, IL-17, and soluble gp130 concentrations were significantly higher in the TS group compared with the control group (P < 0.001); whereas the soluble IL-6 receptor concentration was significantly decreased in the TS group compared with the control group (P < 0.001). Significantly more patients in the TS group were positive for antibrain and antinuclear antibodies, and antistreptolysin compared with the control group (P < 0.05). These findings suggest that immune activity is altered in patients with TS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Autoantibodies / blood*
  • Biomarkers / blood
  • Child
  • Cytokine Receptor gp130 / blood
  • Female
  • Humans
  • Interleukin-17 / blood
  • Interleukin-1beta / blood
  • Interleukin-6 / blood
  • Interleukins / blood*
  • Lymphocytes / immunology
  • Lymphocytes / metabolism
  • Male
  • Receptors, Interleukin-6 / blood
  • Seroepidemiologic Studies
  • Tourette Syndrome / blood
  • Tourette Syndrome / epidemiology
  • Tourette Syndrome / immunology*
  • Young Adult

Substances

  • Autoantibodies
  • Biomarkers
  • IL17A protein, human
  • IL6 protein, human
  • IL6R protein, human
  • Interleukin-17
  • Interleukin-1beta
  • Interleukin-6
  • Interleukins
  • Receptors, Interleukin-6
  • Cytokine Receptor gp130